QLC5508 in Participants With Metastatic Prostate Cancer

NCT07632690 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

700

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: QLC5508
DRUG: Docetaxel

Sponsor

Qilu Pharmaceutical Co., Ltd.